Rosenberg, I. H. Sarcopenia: Origins and clinical relevance. J. Nutr. 127(5 Suppl), 990S-S991 (1997).
Chen, L. K. et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J. Am. Med. Dir. Assoc. 15(2), 95–101 (2014).
Fielding, R. A. et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12(4), 249–56 (2011).
McLean, R. R. et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J. Gerontol. A Biol. Sci. Med. Sci. 69(5), 576–583 (2014).
Morley, J. E. et al. Sarcopenia with limited mobility: An international consensus. J. Am. Med. Dir. Assoc. 12(6), 403–409 (2011).
Muscaritoli, M. et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin. Nutr. 29(2), 154–159 (2010).
Nishikawa, H. et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol. Res. 46(10), 951–963 (2016).
Saito, R. et al. Validity of mid-arm muscular area measured by anthropometry in nonobese patients with increased muscle atrophy and variation of subcutaneous fat thickness. Eur. J. Clin. Nutr. 64(8), 899–904 (2010).
Miller, M. D. et al. Corrected arm muscle area: an independent predictor of long-term mortality in community-dwelling older adults?. J. Am. Geriatr. Soc. 50(7), 1272–1277 (2002).
Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 39(4), 412–423 (2010).
Hamaguchi, Y. et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 32(11–12), 1200–1205 (2016).
Yuri, Y. et al. Implication of psoas muscle index on survival for hepatocellular carcinoma undergoing radiofrequency ablation therapy. J. Cancer. 8(9), 1507–1516 (2017).
Shirai, H. et al. Preoperative low muscle mass and low muscle quality negatively impact on pulmonary function in patients undergoing hepatectomy for hepatocellular carcinoma. Liver Cancer. 7(1), 76–89 (2018).
Marr, K. J. et al. Nutritional status and the performance of multiple bedside tools for nutrition assessment among patients waiting for liver transplantation: A Canadian experience. Clin. Nutr. ESPEN. 17, 68–74 (2017).
Kim, M., Jeong, M. J., Yoo, J., Song, D. Y. & Won, C. W. Calf circumference as a screening tool for cognitive frailty in community-dwelling older adults: The Korean Frailty and Aging Cohort Study (KFACS). J. Clin. Med. 7, 10 (2018).
Ishii, S. et al. Development of a simple screening test for sarcopenia in older adults. Geriatr. Gerontol. Int. 14(Suppl 1), 93–101 (2014).
Tanaka, T., Takahashi, K., Akishita, M., Tsuji, T. & Iijima, K. “Yubi-wakka” (finger-ring) test: A practical self-screening method for sarcopenia, and a predictor of disability and mortality among Japanese community-dwelling older adults. Geriatr. Gerontol. Int. 18(2), 224–232 (2018).
Hiraoka, A. et al. Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test. J. Cachexia Sarcopenia Muscle. 10(2), 347–354 (2019).
Onishi, S. et al. Prevalence of sarcopenia and its relationship with nutritional state and quality of life in patients with digestive diseases. J. Nutr. Sci. Vitaminol. (Tokyo). 64(6), 445–453 (2018).
Yoshida, D. et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr. Gerontol. Int. 14(Suppl 1), 46–51 (2014).
Yoshimura, N. et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos. Int. 28(1), 189–199 (2017).
Hodari, A., Hammoud, Z. T., Borgi, J. F., Tsiouris, A. & Rubinfeld, I. S. Assessment of morbidity and mortality after esophagectomy using a modified frailty index. Ann. Thorac. Surg. 96(4), 1240–1245 (2013).
Nishigori, T. et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J. Surg. Oncol. 113(6), 678–684 (2016).
Fukuda, Y. et al. Prevalence of malnutrition among gastric cancer patients undergoing gastrectomy and optimal preoperative nutritional support for preventing surgical site infections. Ann. Surg. Oncol. 22(3), S778-85 (2015).
Huang, D. D. et al. Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: A prospective study. J. Cancer Res. Clin. Oncol. 142(11), 2347–2356 (2016).
Huang, D. D. et al. Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. Surgery. 161(3), 680–693 (2017).
Lieffers, J. R., Bathe, O. F., Fassbender, K., Winget, M. & Baracos, V. E. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br. J. Cancer. 107(6), 931–936 (2012).
Jung, H. W. et al. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer. 23(3), 687–694 (2015).
Okumura, S. et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann. Surg. Oncol. 24(12), 3732–3740 (2017).
Peng, P. et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J. Gastrointest. Surg. 16(8), 1478–1486 (2012).
Hanai, T. et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 31(1), 193–199 (2015).
Takada, H. et al. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS ONE 13(6), e0198812 (2018).
Harimoto, N. et al. Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol. Res. 46(12), 1247–1255 (2016).
Iritani, S. et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J. Gastroenterol. 50(3), 323–332 (2015).
Ebadi, M. et al. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J. Cachexia Sarcopenia Muscle. 9(6), 1053–1062 (2018).
Kang, S. H., Jeong, W. K., Baik, S. K., Cha, S. H. & Kim, M. Y. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score. J. Cachexia Sarcopenia Muscle. 9(5), 860–870 (2018).
Hiraoka, A. et al. Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib. Hepatol. Res. 1(10), 12780 (2016).
Peng, S. et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: A comprehensive study. Am. J. Clin. Nutr. 85(5), 1257–1266 (2007).
Riggio, O. et al. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin. Nutr. 22(6), 553–559 (2003).
Merli, M., Giusto, M., Giannelli, V., Lucidi, C. & Riggio, O. Nutritional status and liver transplantation. J. Clin. Exp. Hepatol. 1(3), 190–198 (2011).
Alberino, F. et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 17(6), 445–450 (2001).
Merli, M., Riggio, O. & Dally, L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 23(5), 1041–1046 (1996).
Wu, L. W. et al. Mid-arm muscle circumference as a significant predictor of all-cause mortality in male individuals. PLoS ONE 12(2), e0171707 (2017).